ACT IV: the final act for rindopepimut?

Lancet Oncol. 2017 Oct;18(10):1294-1296. doi: 10.1016/S1470-2045(17)30619-8. Epub 2017 Aug 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cancer Vaccines*
  • Glioblastoma*
  • Humans
  • United States
  • Vaccines, Subunit

Substances

  • Cancer Vaccines
  • Vaccines, Subunit
  • rindopepimut